205 related articles for article (PubMed ID: 25047018)
1. The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever...
Bodei L; Kidd M; Prasad V; Baum RP; Drozdov I; Modlin IM
Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2189-93. PubMed ID: 25047018
[No Abstract] [Full Text] [Related]
2. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
3. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP132-9. PubMed ID: 14989227
[No Abstract] [Full Text] [Related]
4. Nuclear medicine in the treatment of neuroendocrine tumours--problems and perspectives.
Grzela T; Bialoszewska A; Brawura-Biskupski-Samaha R
Eur J Nucl Med Mol Imaging; 2007 Apr; 34(4):444-7. PubMed ID: 17136539
[No Abstract] [Full Text] [Related]
5. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
Schillaci O
J Nucl Med; 2007 Apr; 48(4):498-500. PubMed ID: 17401084
[No Abstract] [Full Text] [Related]
6. Is PET the future of nuclear medicine?
Maisey M
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1045-6. PubMed ID: 12827314
[No Abstract] [Full Text] [Related]
7. Is PET the future of nuclear medicine?
Bailey DL
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1047-9. PubMed ID: 12811533
[No Abstract] [Full Text] [Related]
8. General nuclear medicine.
Ziessman HA
J Nucl Med; 2011 Nov; 52(11):20N-8N. PubMed ID: 22045712
[No Abstract] [Full Text] [Related]
9. [Nuclear medicine].
Vallens D; Wahart G; Bougaud A
J Radiol; 2002; 83(7-8):961-4. PubMed ID: 12223934
[No Abstract] [Full Text] [Related]
10. SNMMI leadership update: reaching out to develop a unified voice.
Herscovitch P
J Nucl Med; 2015 Mar; 56(3):16N. PubMed ID: 25733604
[No Abstract] [Full Text] [Related]
11. Demystifying nuclear medicine.
Bean B
Biomed Instrum Technol; 2009; Suppl():31-5. PubMed ID: 19891110
[No Abstract] [Full Text] [Related]
12. Nuclear Medicine Imaging of Neuroendocrine Tumors.
Brabander T; Kwekkeboom DJ; Feelders RA; Brouwers AH; Teunissen JJ
Front Horm Res; 2015; 44():73-87. PubMed ID: 26303705
[TBL] [Abstract][Full Text] [Related]
13. Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours.
Cuccurullo V; Di Stasio GD; Mansi L
Curr Radiopharm; 2019; 12(2):98-106. PubMed ID: 30727940
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in nuclear medicine in endocrine oncology.
Luster M; Pfestroff A; Verburg FA
Curr Opin Oncol; 2017 Jan; 29(1):1-6. PubMed ID: 27906859
[TBL] [Abstract][Full Text] [Related]
15. Interventional Molecular Imaging.
Solomon SB; Cornelis F
J Nucl Med; 2016 Apr; 57(4):493-6. PubMed ID: 26912443
[TBL] [Abstract][Full Text] [Related]
16. Who should read and interpret 18F-FDG PET studies?
Fischman AJ; Thrall JH
J Nucl Med; 2003 Aug; 44(8):1197-9. PubMed ID: 12902407
[No Abstract] [Full Text] [Related]
17. Nuclear medicine imaging of neuroendocrine tumours.
Bombardieri E; Maccauro M; De Deckere E; Savelli G; Chiti A
Ann Oncol; 2001; 12 Suppl 2():S51-61. PubMed ID: 11762353
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceuticals for the Diagnosis and Therapy of Neuroendocrine Differentiated Prostate Cancer.
Giovacchini G; Giovannini E; Riondato M; Ciarmiello A
Curr Radiopharm; 2017; 10(1):6-15. PubMed ID: 28034291
[TBL] [Abstract][Full Text] [Related]
19. [Gastroenteropancreatic neuroendocrine tumors: diagnosis and therapy in nuclear medicine].
Haug AR; Bartenstein P
Internist (Berl); 2012 Feb; 53(2):161-6. PubMed ID: 22231696
[TBL] [Abstract][Full Text] [Related]
20. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors].
Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
